title: Obstacles to adherence to azacitidine administration schedule in outpatient myelodysplastic syndrome and related disorders.
authors.affiliation: Hematology Unit and Department of Pharmacy Services, Sant'Eugenio Hospital, Rome, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Tendas
authors.forename: Maria Felicita
authors.initials: MF
authors.lastname: Lissia
authors.forename: Daniela
authors.initials: D
authors.lastname: Piccioni
authors.forename: Liliana
authors.initials: L
authors.lastname: Tirimbelli
authors.forename: Laura
authors.initials: L
authors.lastname: Scaramucci
authors.forename: Marco
authors.initials: M
authors.lastname: Giovannini
authors.forename: Teresa
authors.initials: T
authors.lastname: Dentamaro
authors.forename: Alessio
authors.initials: A
authors.lastname: Perrotti
authors.forename: Paolo
authors.initials: P
authors.lastname: de Fabritiis
authors.forename: Pasquale
authors.initials: P
authors.lastname: Niscola
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D010045:Outpatients
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine